Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
The Dangers of PRES
Neurol 92:e282-e285, Chaterine, C.,et al, 2019
Maternal and Fetal Risks of Natalizumab Exposure in Utero
Neurol 90:443-444, Marrie, R.A.,et al, 2018
Recrudescence of Deficits After Stroke
JAMA Neurol 74:1048-1055, Topcuoglu, M.A.,et al, 2017
A 35-Year-Old Man with 2 Episodes of Meningoencephalitis Associated with Flu-Like Illness
Neurol 84:e60-e64, Lewis, S.L., 2015
Tumefactive MS Lesions under Fingolimod
Neurol 81:1654-1658, Pilz, G.,et al, 2013
Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults
JAMA 307:1736-1745, Jackson,J.L.,et al, 2012
Multimodal Imaging of Reversible Cerebral Vasoconstriction Syndrome: A Series of 6 Cases
AJNR 33:1403-1410, Marder, C.P.,et al, 2012
Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012
Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011
Headache and Pregnancy
The Neurologist 14:108-119, Menon,R. &Bushnell,C.D., 2008
Medication-Overuse Headache in Patients With Cluster Headache
Neurol 67:109-113, Paemeleire,K.,et al, 2006
Recurrent Ibuprofen-Induced Aseptic Meningitis: Evidence Against an Antigen-Specific Immune Response
Neurol 67:539-540, Periard,D.,et al, 2006
Verapamil Induced Gingival Enlargement in Cluster Headache
JNNP 76:124-127, Matharu,M.S.,et al, 2005
Riversible Diffusion MRI Abnormalities and Transient Mutism after Liver Trnasplantation
Neurol 62:981-983, Bianco,F.,et al, 2004
Reversible Tacrolimus-Induced Neurotoxicity Isolated to the Brain Stem
AJNR 21:1251-1254, Oliverio,P.J. et al, 2000
Drug Points, Transient Hemiparesis with Topiramate
BMJ 318:845, Stephen,L.J.,et al, 1999
Acute Therapy for Cluster Headache with Sumatriptan:Findings of a One-Year Long-Term Study
Neurol 51:980-911, Gobel,H.,et al, 1998
Transient Encephalopathy after Paclitaxel (Taxol) Infusion
Neurol 46:1596-1599, Perry,J.R.&Warner,E., 1996
Immunosuppression-Induced Leukoencephalopathy from Tacrolimus (FK506)
Ann Neurol 40:575-580, Small,S.L.,et al, 1996
Neurotoxicity in Liver Transplant Recipients with Cyclosporine Immunosuppression
Neurol 45:1962-1964, Wijdicks,E.F.M.,et al, 1995
Baclofen-induced Generalized Nonconvulsive Status Epilepticus
Ann Neurol 36:113-114, Zak,R.,et al, 1994
Drug-Induced Aseptic Meningitis Caused by Two Medications
Neurol 44:984-985, Davis,B.J.,et al, 1994
Antibiotic Induced Meningitis
JNNP 57:705-708, River,Y.,et al, 1994
Clinical Exper from Sweden on Use of Subcutaneously Admin Sumatriptan in Migraine & Cluster Headache
Arch Neurol 51:1256-1261, Dahlof,C.,et al, 1994
Contrast Agent Overdose Causing Brain Retention of Contrast, Seizures, and Parkinsonism
Neurol 43:836-838, May,E.F.,et al, 1993
Ifosfamide-Induced Nonconvulsive Status Epilepticus
Arch Neurol 50:1104-1105, Wengs,W.J.,et al, 1993
Periodic Triphasic Waves in Levodopa-Induced Encephalopathy
Neurol 42:444-446, Neufeld,M.Y., 1992
Recurrent Aseptic Meningitis Complicating Intravenous Immunoglobulin Therapy for CIDP
Neurol 42:1636-1637, Vera-Ramirez,M.,et al, 1992
Sumatriptan for Migraine
The Medical Letter, 34:91-931992., , 1992
Osteogenic Sarcoma:MR Signal Abnormalities of the Brain in Asymptomatic Patients Treated with High-Dose Methotrexate
Radiology 179:547-550, Lien,H.H.,et al, 1991
Treatment of Acute Cluster Headache with Sumatriptan
The Sumatriptan Cluster Headache Study Group, NEJM 325:322-326, 353-354991., , 1991
A Creutzfeldt-Jakob Like Syndrome Due to Lithium Toxicity
JNNP 51:120-123, Smith,S.J.M.&Kocen,R.S., 1988
Transient Expressive (Nonfluent) Dysphasia after Metrizamide Myelography
AJNR 6:945-947, Sarno, J.B.,et al, 1985
Periodic Alternating Nystagmus in Phenytoin Intoxication
Arch Neurol 37:178-180, Campbell,W.W., 1980
Adverse Events Associated with Disease-Modifying Drugs for Multiple Sclerosis
Neurol 102:e208006, Ng, HS.,et al, 2024
Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023
Autoimmune Encephalitis Misdiagnosis in Adults
JAMA Neurol 80:30-39, Flanagan,E.P.,et al, 2023
Phase 2 Trial of Difelikefalin in Notalgia Paresthetica
NEJM 388:511-517, Kin,B.S.,et al, 2023
Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinsons Disease
NEJM 388:683-693, 759, Krishna,V.,et al, 2023
New-Onset Diplopia and Headache in a Patient with Metastatic Breast Cancer
Neurol 100:927-931, Rizzo,S.A.,et al, 2023
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023
NSAIDS, Hormonal Contraception, and Venous Thromboembolism, A Harmful Drug Interaction That Deserves More Attention
BMJ 382:p1990, Schmidt,M., 2023
Trial of Botulinum Toxin for Isolated or Essential Head Tremor
NEJM 389:1753-1765, Marques,A.,et al, 2023
Severe Amyloid-Related Imaging Abnormalities After Anti-B-Amyloid Monoclonal Antibody Treatment
Neurol 101:1079-1080, Bonami,S.,et al, 2023
Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Patients with Melanoma
Neurol 101:e2472-e2482, Pepys,J.,et al, 2023
Cannabis-Related Disorders and Toxic Effects
NEJM 389: 2267-2275, Gorelick,D.A., 2023